Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Mohammad Rafieetary, OD, FAAO
Advertisement
Articles by Mohammad Rafieetary, OD, FAAO
Advertisement
Latest Updated Articles
A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lweyPublished: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
Inner plexiform layer substrata: Possible biomarker of retinal health
4
IGS 2026: The expanding role of artificial intelligence in ophthalmology
5